Saudi Leukemia Net retweeted
هذا الرجل اسمه "أحمد الدوسري" مصاب بالهيموفيليا وهو مرض يمنع تجلط الدم.
xitter.cf/CGCSaudi/status/210269…
يسرد أحمد معانته مع المرض خلال عشرات السنين ووفاة أخوانه بسببه، وفي النهاية أخبره الطبيب بوجود علاج عبارة عن إبرة واحدة تؤخذ في الوريد.. وعندما سأل كم سعرها؟ صُدم من الإجابة (13 مليون ريال).. أحمد لم يدفع شيء، بل تكفلت الدولة بذلك.
شفت مقاطع كثير لليوم الوطني، لكن هذا أكثر مقطع أثّر فيني.
Credits: @CGCSaudi
Saudi Leukemia Net retweeted
#التخصصي ينجح في تطبيق العلاج الجيني لمريض مصاب بفقر الدم المنجلي، عبر تعديل الخلايا الجذعية المكوِّنة للدم لتصحيح الخلل الوراثي المسبب للمرض، ثم إعادة حقنها في جسم المريض، ضمن دراسة سريرية تهدف إلى توسيع الخيارات العلاجية المتاحة للحالات غير المؤهلة للخضوع لزراعة خلايا جذعية من متبرعين.
للمزيد من المعلومات: kfshrc.edu.sa/ar/news/2026/0…
Saudi Leukemia Net retweeted
Very honored to write this review on the genetics of coronary artery disease with Prof H. Schunkert and Sir N. Samani nejm.org/doi/full/10.1056/NE… @NEJM
New Review Article: The Inherited Basis of Coronary Artery Disease 👉 nej.md/4tmGZtI
Coronary artery disease develops from an interplay of behavioral, environmental, genetic, and stochastic factors. Smoking, hypertension, hyperlipidemia, and diabetes mellitus are well-recognized modifiable risk factors for coronary artery disease, which affects almost 1 in 2 men and 1 in 3 women during their lifetime. More than a century ago, Osler posited that inherited factors may cause coronary artery disease after he observed that angina pectoris often clusters in families. Approximately 30 years ago, twin studies indicated that the heritability of fatal coronary artery disease was as high as 50%. Since 2007, large-scale genotyping and gene-sequencing studies have identified hundreds of genetic variants associated with increased susceptibility to coronary artery disease (seen in figure). Protein products of some associated genes already constitute effective treatment targets, and other genes point to currently unexplored disease mechanisms.
An inquiry about a family history of coronary artery disease is routine in the clinical assessment of patients presenting with chest pain syndromes. Heribert Schunkert, MD, Pradeep Natarajan, MD (@pnatarajanmd), and Nilesh J. Samani, MD, review recent discoveries regarding the molecular genetic origins of coronary atherosclerosis and discuss current and potential clinical uses of this information.
Read the Review Article “The Inherited Basis of Coronary Artery Disease” from Universitätsklinikum der Technischen Universität München; Deutsches Zentrum für Herz- und Kreislaufforschung, Partner Site Munich Heart Alliance (@dzhk_germany); and elsewhere: nej.md/4tmGZtI
Saudi Leukemia Net retweeted
Genuinely excited to be finally able to fully share the first major output from the MEASURE consortium at #ASH25 #ASH2025 - the largest cohort of paired tumor and remission WGS from patients with AML meetings-api.hematology.org/…
Saudi Leukemia Net retweeted
🚨 This is it people … you heard it first at #ASH25 🚨
ELN #MRD 205 guidelines are in press in @BloodPortfolio
Bad news: It’s more complicated than before… 🤯
Good news: there’s an app for it 😉
eln-aml-mrd-2025.vercel.app/
Saudi Leukemia Net retweeted
Anticoagulation strategies in hematologic malignancies with thrombocytopenia
Very nice summarised figure
#ASH25
@Ruah_Mahmoud
@dhoughton
Saudi Leukemia Net retweeted
This retrospective single-center study evaluates high-dose melphalan followed by busulfan/fludarabine conditioning in elderly patients with active #AML. Three-year overall survival was 44% and 40% of patients remained relapse-free. ow.ly/a5z650XkxvR
Saudi Leukemia Net retweeted
The description of regulatory T cells and connection to FoxP3 is a beautiful story for #Science and the #NobelPrize
BREAKING NEWS
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
Saudi Leukemia Net retweeted
نجح #التخصصي بالرياض في علاج أول مريضة باستخدام الخلايا التائية المعدلة وراثياً، والمصنّعة محلياً، وذلك ضمن المرحلة الأولى من بحث سريري يستهدف مرضى سرطان الدم الليمفاوي الحاد المقاوم، في إنجاز نوعي يسهم في توطين العلاجات الجينية والخلوية بالمملكة.
لمزيد من المعلومات: kfshrc.edu.sa/ar/news/2025/0…
Saudi Leukemia Net retweeted
KFSHRC Reinforces Global Leadership as Early Adopter of Advanced Cell and Gene Therapies.
spa.gov.sa/ar/w2390144
#SPAGOV
Saudi Leukemia Net retweeted
مدير قسم الأبحاث السريرية بمستشفى الملك فيصل التخصصي د. رياض الفقيه يشرح سرطان ابيضاض الدم اللمفاوي الحاد ومدى خطورته
#نشرة_التاسعة
#MBC1
Saudi Leukemia Net retweeted
The effects of graft cryopreservation on patient outcomes in allogeneic HCT remain unclear. This UK study of cryopreserved vs. fresh allogeneic HCT found no statistically significant difference in overall survival at 12-month follow-up. For more: tinyurl.com/4zz4vs2u
Saudi Leukemia Net retweeted
Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series | Communications
@NatureMedicine @KFSHRC @KFSHRC_Research
The 1st case series...
Proud of our team nature.com/articles/s43856-0…
Saudi Leukemia Net retweeted
ليست مجرد خلايا تُزرع، بل قصة تُكتب؛ الدكتور محمود الجرف غدًا في المنافس العالمي.
Saudi Leukemia Net retweeted
There have been major advances in #ALL therapy over the last decade. Check out our review just published in @JournalCancer discussing these advances & revolution in adult ALL therapy
@MDAndersonNews #Leukemia
@NitinJainMD @NicholasShortMD Jabbour
doi.org/10.1002/cncr.35872
#leusm
Saudi Leukemia Net retweeted
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia ashpublications.org/blood/ar…
70 cases of B-cell #ALL with lineage switch after immunotherapy (anti-CD19) to AML or mixed phenotypic leukemia.
Dismal outcome with median OS 4.9 months.
#leusm @BloodPortfolio
Saudi Leukemia Net retweeted
emjreviews.com/hematology/jo…
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias: highlights from #EHA2025 #EHA25
Saudi Leukemia Net retweeted
I can't understand e.g. if the stem cell lab refused to release the specifications of cellular therapy product e.g. CD34, TNC,etc...
Where is the quality?
#Novartis more practical in the this issue
Saudi Leukemia Net retweeted
🚨NEW - In vivo CAR T cell generation to treat cancer and autoimmune disease @capstantx direct delivery of mRNA-encoded CARs to CD8+ T cells in mouse & NHP models shows tumor control not only in blood, but also tissue. Immune reset seen at B cell recovery science.org/doi/10.1126/scie…
Saudi Leukemia Net retweeted
CREM de la CREM
🧵1/
T cells have deservedly been in the🔦for #cancer #immunotherapy, but other engineered cell therapies are now📈. What mediates NK cell exhaustion remains an important unanswered❓.
📄Link: nature.com/articles/s41586-0…
I’m so thrilled🥳to share our work out now🚨@Nature identifying🔎CREM as a central intracellular checkpoint🚦in #CARNK cells.
Let me tell you a story...👇🏼


































